Driven by the Pinova acquisition, sales rose +10% (organic: +9%) to €731m, but the gross profit margin weakened from 43.5% to 41.9%. EBITDA was up +5% to €159m and net profit attributable to shareholders came in at €68m (€66m). H1 operating CF was up +16% to €100m benefiting from higher D/A as NWC remained fairly unchanged. Investing CF (€-230m after €-74m) reflected the acquisition of Pinova (€-145m), Scelta (€-8m) and Nutra Canada (€-4m) and
11 Aug 2016
Profitability is worth a second look
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Profitability is worth a second look
Symrise AG (SY1:WBO) | 0 0 1.0% | Mkt Cap: 8,612m
- Published:
11 Aug 2016 -
Author:
Martin Schnee -
Pages:
3
Driven by the Pinova acquisition, sales rose +10% (organic: +9%) to €731m, but the gross profit margin weakened from 43.5% to 41.9%. EBITDA was up +5% to €159m and net profit attributable to shareholders came in at €68m (€66m). H1 operating CF was up +16% to €100m benefiting from higher D/A as NWC remained fairly unchanged. Investing CF (€-230m after €-74m) reflected the acquisition of Pinova (€-145m), Scelta (€-8m) and Nutra Canada (€-4m) and